IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — XERS

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q3 2023Q3 2022Q2 2022Q1 2022Q3 2021
Cash & Equivalents121.75111.7591.6059.2958.4459.2357.6046.1484.1195.34103.7759.49
Short-term Investments----------10.1719.9619.839.3216.2128.3833.49
Accounts Receivable58.1156.3053.7553.0546.3341.1442.4445.9727.5225.7623.38--
Inventory80.9374.2367.4667.2852.6945.1242.9838.1420.1217.8916.8714.24
Total Current Assets274.76251.68224.02185.58163.49162.80170.34158.05148.92161.21177.55124.37
Property, Plant & Equipment4.835.034.955.285.265.615.836.195.756.176.296.68
Goodwill22.8622.8622.8622.8622.8622.8622.8622.8622.8622.8622.86--
Intangible Assets82.6685.3790.7993.5096.21101.63104.34112.48123.32126.03128.74--
Total Non-current Assets*137.15140.33146.17149.11151.96158.31161.39169.73154.10157.41160.076.89
Total Assets411.91392.01370.19334.69315.45321.10331.73327.78303.02318.62337.62131.26
Accounts Payable9.3411.476.539.466.357.455.8012.083.926.6311.094.29
Total Current Liabilities189.57118.59116.2095.1795.0791.0175.4987.0468.5664.5566.4937.28
Long-term Debt252.59221.22219.47218.63229.76216.23230.48190.42138.51138.07137.6487.71
Total Non-current Liabilities*232.07260.41254.85258.82255.51258.41275.53236.88179.42180.13174.6896.44
Total Liabilities421.64379.00371.05353.99350.58349.43351.02323.92247.98244.67241.17133.72
Retained Earnings(700.17)(669.07)(682.39)(683.01)(681.08)(666.75)(651.01)(603.63)(541.84)(520.01)(493.82)(409.32)
Total Stockholder Equity(9.73)13.01(0.86)(19.30)(35.13)(28.32)(19.29)3.8755.0473.9496.46(2.46)

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q4 2023Q3 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue92.1083.1385.8174.3871.5460.1260.1054.2748.0744.3948.3233.3129.7325.3121.9121.3611.04
Cost of Revenue--------------------------------3.22
Gross Profit--------------------------------7.84
Research & Development10.678.787.877.488.067.756.095.895.766.385.034.966.043.726.2510.085.66
Selling, General & Admin61.0453.1447.5046.4644.3944.0240.1444.9739.9937.5737.2934.3634.4932.9835.9154.1826.54
Total Operating Expenses--------------------------------32.20
Operating Income5.177.9216.776.734.48(3.09)1.68(12.89)(8.19)(9.84)(4.91)(15.17)(18.78)(18.92)(29.07)(48.27)(24.36)
Interest Expense------------------7.026.854.373.993.453.521.801.80
Pretax Income*(31.10)2.2311.080.62(1.93)(9.22)(5.11)(19.06)(14.26)(13.63)(12.53)(13.27)(22.17)(26.52)(34.12)(50.79)(26.01)
Tax Provision0.000.000.000.000.000.000.00(3.32)0.75(0.24)(0.34)(0.34)(0.34)(0.34)(0.41)0.000.00
Net Income(31.10)2.2311.080.62(1.93)(9.22)(5.11)(15.74)(15.00)(13.39)(12.19)(12.93)(21.83)(26.18)(33.71)(50.79)(26.01)
Basic EPS(0.18)0.010.070.00(0.01)(0.06)(0.03)(0.11)(0.10)(0.09)(0.09)(0.10)(0.16)(0.19)(0.25)----
Diluted EPS(0.18)0.010.070.00(0.01)(0.06)(0.03)(0.11)(0.10)(0.09)(0.09)(0.10)(0.16)(0.19)(0.25)----

* Derived from reported values

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q4 2023Q3 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow8.269.8720.0418.430.18(10.03)1.98(8.30)(30.65)7.47(54.49)(16.12)(17.75)(20.61)(48.41)(28.95)(66.59)
Capital Expenditures--------------------------------0.95
Free Cash Flow*--------------------------------(67.54)
Investing Cash Flow(0.21)(0.32)(0.33)(0.07)(0.28)(0.01)10.029.91(15.05)14.87(20.87)9.176.7111.876.7236.6061.36
Financing Cash Flow1.94(8.84)(0.27)13.850.94(3.14)0.40(0.08)35.85(1.23)(0.38)49.16(0.19)0.3178.190.1327.12

* Derived from reported values